- Tytuł:
- A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
- Autorzy:
- Temat:
-
Parkinson's disease
alpha-synuclein (α-syn)
prasinezumab
monoclonal antibodies
disease progression
MDS-UPDRS = Movement Disorder Society—Unified Parkinson's Disease Rating Scale
Neurology. Diseases of the nervous system
RC346-429 - Źródło:
- Frontiers in Neurology, Vol 12 (2021)
- Opis pliku:
- electronic resource
- Relacje:
- https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/full; https://doaj.org/toc/1664-2295
- Dostęp URL:
- https://doaj.org/article/a1132dd1342e45bda3945621de12e3fd  Link otwiera się w nowym oknie
Czasopismo naukowe